相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
Florian P. Maurer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus
Mary Ann De Groote et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
Richard J. Wallace et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Genome Sequencing of Mycobacterium abscessus Isolates from Patients in the United States and Comparisons to Globally Diverse Clinical Strains
Rebecca M. Davidson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
Isabelle Lerat et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
High-level Relatedness among Mycobacterium abscessus subsp massiliense Strains from Widely Separated Outbreaks
Herve Tettelin et al.
EMERGING INFECTIOUS DISEASES (2014)
Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45
Yoshimasa Ishizaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Comparative Drug Resistance of Mycobacterium abscessus and M. chelonae Isolates from Patients with and without Cystic Fibrosis in the United Kingdom
Agnieszka Broda et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
New Rapid Scheme for Distinguishing the Subspecies of the Mycobacterium abscessus Group and Identifying Mycobacterium massiliense Isolates with Inducible Clarithromycin Resistance
Shamira J. Shallom et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
Josephine M. Bryant et al.
LANCET (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Kapil Tahlan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activity of TP-271 against Mycobacterium abscessus, Mycobacterium fortuitum, and Nocardia Species
Michael Cynamon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
Barbara A. Brown-Elliott et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
Katherine A. Sacksteder et al.
FUTURE MICROBIOLOGY (2012)
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The Talking Mycobacterium abscessus Blues
David E. Griffith
CLINICAL INFECTIOUS DISEASES (2011)
In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium Species
Areeya Disratthakit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria
Tia Dubuisson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal
Nacer Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
Kevin A. Nash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
Thierry Christophe et al.
PLOS PATHOGENS (2009)
In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor
Emma Huitric et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Tigecycline: A critical analysis
Gary E. Stein et al.
CLINICAL INFECTIOUS DISEASES (2006)
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines
M Protopopova et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo
T Koga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: Substitution of the azepan-2-one moiety of capuramycin
H Hotoda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Comparison of the in vitro activity (formerly GAR-936) with those of tetracycline, minocycline, and deoxycycline against isolates of nontuberculous mycobaceria
RJ Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
分享论文
